For 22 years, Jason Mazzola’s life was defined by Fragile X, a genetic condition that often causes autism and intellectual disability.
Jason, who is 24 now, needed constant supervision. He had disabling anxiety, and struggled to answer even simple questions.
All that began to change when he started taking an experimental drug called zatolmilast in May of 2023.
“It helps me focus a lot, helps me get more confident, more educated,” Jason says.
His mother, Lizzie Mazzola, credits zatolmilast with transforming her son.
“I have a different child in my house,” she says. “He gets himself to work, he walks downtown, gets his haircut, gets lunch. He wouldn’t have done any of that before.”
